Multiplex Assay Kit for Inducible T-Cell Co Stimulator Ligand (ICOSLG) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD275; B7-H2; B7H2; B7RP-1; B7RP1; GL50; ICOS-L; ICOSL; LICOS; B7-like protein Gl50; B7-related protein 1

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Inducible T-Cell Co Stimulator Ligand (ICOSLG) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Inducible T-Cell Co Stimulator Ligand (ICOSLG) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Inducible T-Cell Co Stimulator Ligand (ICOSLG) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Inducible T-Cell Co Stimulator Ligand (ICOSLG) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 84-102 97
EDTA plasma(n=5) 81-102 88
heparin plasma(n=5) 83-103 88
sodium citrate plasma(n=5) 89-96 93

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Inducible T-Cell Co Stimulator Ligand (ICOSLG) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Inducible T-Cell Co Stimulator Ligand (ICOSLG) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Inducible T-Cell Co Stimulator Ligand (ICOSLG) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 95-102% 87-99% 92-99% 90-98%
EDTA plasma(n=5) 85-101% 94-103% 92-103% 79-97%
heparin plasma(n=5) 84-93% 84-101% 83-90% 80-95%
sodium citrate plasma(n=5) 96-103% 78-90% 81-90% 81-97%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:ICOSLG) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
中华疾病控制杂志 可诱导共刺激分子配体在系统性红斑狼疮血清中水平及临床意义 2f4qfivv.pdf
Br J Haematol Inducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironment Pubmed:34954822
Diagnostics (Basel) Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases Pubmed:35328257
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA787Hu01 Recombinant Inducible T-Cell Co Stimulator Ligand (ICOSLG) Positive Control; Immunogen; SDS-PAGE; WB.
EPA787Hu61 Eukaryotic Inducible T-Cell Co Stimulator Ligand (ICOSLG) Positive Control; Immunogen; SDS-PAGE; WB.
PAA787Hu01 Polyclonal Antibody to Inducible T-Cell Co Stimulator Ligand (ICOSLG) WB,IHC
FAA787Hu01 Anti-Inducible T-Cell Co Stimulator Ligand (ICOSLG) Polyclonal Antibody Flow cytometry.
MAA787Hu22 Monoclonal Antibody to Inducible T-Cell Co Stimulator Ligand (ICOSLG) WB; IHC; ICC; IP.
MAA787Hu21 Monoclonal Antibody to Inducible T-Cell Co Stimulator Ligand (ICOSLG) WB; IHC; ICC; IP.
SEA787Hu ELISA Kit for Inducible T-Cell Co Stimulator Ligand (ICOSLG) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA787Hu Multiplex Assay Kit for Inducible T-Cell Co Stimulator Ligand (ICOSLG) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.